Moffitt’s HPV Research Impacts Practice and Policy Worldwide

When people hear the phrase cancer research, they usually think about cutting-edge immunotherapies, clinical trials or lab work using cells and...

Grand Opening of New Moffitt Clinic Dedicated to Immune Cell Therapy

The new clinic will focus on cellular immunotherapies such as chimeric antigen receptor T-cell therapy (CAR T), which reengineers a patient’s own...

Novel Drug Delivery Tool Enhances Treatment of Recurrent Glioblastoma

Convection enhanced delivery (CED) involves the placement of one or more catheters into brain tumors and tumor-infiltrated brain in order to slowly...

Innovative 3D Visualization Technology Enhances Brain Cancer Treatment

The Neuro-Oncology Program is using a novel 3D surgical exoscope called the Orbeye. This technology uses a dye called 5-Aminolevulinic Acid, or...

Moffitt Researchers Utilize the Genomic-Adjusted Radiation Dose to Personalize Radiotherapy in Cancer Care

Utilizing the linear quadratic model and the radiosensitivity index (RSI), we have derived an expression for the genomically adjusted radiation dose...